GERN
Geron Corp
Price:  
1.66 
USD
Volume:  
26,457,668.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-261.8%
Upside

As of 2026-04-04, the Relative Valuation of Geron Corp (GERN) is (2.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.66 USD, the upside of Geron Corp based on Relative Valuation is -261.8%.

The range of the Relative Valuation is (2.46) - (2.80) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.9x - 22.7x 20.4x
Forward P/E multiples 18.0x - 21.5x 20.8x
Fair Price (2.46) - (2.80) (2.69)
Upside -248.4% - -268.5% -261.8%
1.66 USD
Stock Price
(2.69) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2026-03-31 -11.43
2026-03-30 -10.82
2026-03-27 -10.74
2026-03-26 -11.81
2026-03-25 -12.04
2026-03-24 -11.58
2026-03-23 -11.81
2026-03-20 -11.20
2026-03-19 -11.89
2026-03-18 -11.89
2026-03-17 -12.43
2026-03-16 -12.66
2026-03-13 -12.12
2026-03-12 -12.27
2026-03-11 -12.73
2026-03-10 -12.50
2026-03-09 -12.43
2026-03-06 -11.74
2026-03-05 -10.89
2026-03-04 -11.28
2026-03-03 -11.05
2026-03-02 -11.89
2026-02-27 -12.89
2026-02-26 -12.66
2026-02-25 -13.19
2026-02-24 -14.96
2026-02-23 -13.58
2026-02-20 -14.42
2026-02-19 -14.73
2026-02-18 -14.88
2026-02-17 -13.81
2026-02-13 -12.66
2026-02-12 -12.50
2026-02-11 -12.35
2026-02-10 -12.43
2026-02-09 -12.35
2026-02-06 -11.74
2026-02-05 -11.20
2026-02-04 -11.28
2026-02-03 -11.58
2026-02-02 -11.81
2026-01-30 -10.51
2026-01-29 -10.51
2026-01-28 -10.20
2026-01-27 -10.59
2026-01-26 -10.51
2026-01-23 -10.59
2026-01-22 -10.82
2026-01-21 -10.28
2026-01-20 -9.97